[go: up one dir, main page]

DE69618574D1 - Vom desmingen abstammende amplifizierungssequenzen, vektoren, die diese enthalten und anwendungen derselben zur herstellung von proteinen - Google Patents

Vom desmingen abstammende amplifizierungssequenzen, vektoren, die diese enthalten und anwendungen derselben zur herstellung von proteinen

Info

Publication number
DE69618574D1
DE69618574D1 DE69618574T DE69618574T DE69618574D1 DE 69618574 D1 DE69618574 D1 DE 69618574D1 DE 69618574 T DE69618574 T DE 69618574T DE 69618574 T DE69618574 T DE 69618574T DE 69618574 D1 DE69618574 D1 DE 69618574D1
Authority
DE
Germany
Prior art keywords
sequences
sequence
applications
proteins
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69618574T
Other languages
English (en)
Other versions
DE69618574T2 (de
Inventor
Denise Paulin
Lin Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Paris Diderot Paris 7
Institut Pasteur
Original Assignee
Universite Paris Diderot Paris 7
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Paris Diderot Paris 7, Institut Pasteur filed Critical Universite Paris Diderot Paris 7
Application granted granted Critical
Publication of DE69618574D1 publication Critical patent/DE69618574D1/de
Publication of DE69618574T2 publication Critical patent/DE69618574T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69618574T 1995-02-20 1996-02-16 Vom desmingen abstammende amplifizierungssequenzen, vektoren, die diese enthalten und anwendungen derselben zur herstellung von proteinen Expired - Fee Related DE69618574T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9501937A FR2730735B1 (fr) 1995-02-20 1995-02-20 Sequences amplificatrices, vecteurs portant ces sequences et leurs utilisations dans des compositions pour l'expression de sequences nucleotidiques dans des cellules transfectees, applications therapeutiques et vaccinales
PCT/FR1996/000261 WO1996026284A1 (fr) 1995-02-20 1996-02-16 Sequences amplificatrices derivees du gene de la desmine, vecteurs portant ces sequences et leurs utilisations pour la production de proteines

Publications (2)

Publication Number Publication Date
DE69618574D1 true DE69618574D1 (de) 2002-02-21
DE69618574T2 DE69618574T2 (de) 2002-08-14

Family

ID=9476320

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618574T Expired - Fee Related DE69618574T2 (de) 1995-02-20 1996-02-16 Vom desmingen abstammende amplifizierungssequenzen, vektoren, die diese enthalten und anwendungen derselben zur herstellung von proteinen

Country Status (15)

Country Link
US (2) US5914395A (de)
EP (1) EP0811071B1 (de)
JP (1) JPH11500905A (de)
AT (1) ATE212060T1 (de)
AU (1) AU710697B2 (de)
CA (1) CA2211435A1 (de)
DE (1) DE69618574T2 (de)
DK (1) DK0811071T3 (de)
ES (1) ES2168459T3 (de)
FR (1) FR2730735B1 (de)
IL (1) IL117194A0 (de)
MX (1) MX9706290A (de)
PT (1) PT811071E (de)
WO (1) WO1996026284A1 (de)
ZA (1) ZA961349B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2246664A1 (en) * 1998-10-02 2000-04-02 Universite Paris 7 Vascular specific regulatory elements contained in the desmin 5' flanking region
EP1925626A1 (de) 2003-07-21 2008-05-28 Transgene S.A. Neue multifunktionelle Cytokine
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
CN109134640A (zh) 2012-10-23 2019-01-04 爱默蕾大学 Gm-csf和il-4轭合物、组合物以及与其相关的方法
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
WO2015110449A1 (en) 2014-01-21 2015-07-30 Vrije Universiteit Brussel Muscle-specific nucleic acid regulatory elements and methods and use thereof
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723075A1 (de) * 1987-07-11 1989-01-19 Boehringer Mannheim Gmbh Eukaryotische expressionsvektoren mit multimeren enhancer-subelementen, verfahren zu ihrer herstellung und verwendung
US5503980A (en) * 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization

Also Published As

Publication number Publication date
ZA961349B (en) 1996-09-05
MX9706290A (es) 1998-02-28
DK0811071T3 (da) 2002-04-29
US6201115B1 (en) 2001-03-13
FR2730735A1 (fr) 1996-08-23
FR2730735B1 (fr) 1997-05-09
IL117194A0 (en) 1996-06-18
CA2211435A1 (fr) 1996-08-29
EP0811071A1 (de) 1997-12-10
ES2168459T3 (es) 2002-06-16
ATE212060T1 (de) 2002-02-15
AU710697B2 (en) 1999-09-30
JPH11500905A (ja) 1999-01-26
US5914395A (en) 1999-06-22
WO1996026284A1 (fr) 1996-08-29
DE69618574T2 (de) 2002-08-14
AU4835696A (en) 1996-09-11
PT811071E (pt) 2002-07-31
EP0811071B1 (de) 2002-01-16

Similar Documents

Publication Publication Date Title
DE69618574D1 (de) Vom desmingen abstammende amplifizierungssequenzen, vektoren, die diese enthalten und anwendungen derselben zur herstellung von proteinen
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
CA2120514A1 (en) Synthetic dna sequence having enhanced insecticidal activity in maize
EE9900581A (xx) LAG-3 pleissimisteisendid
AU7891498A (en) Flower organ-specific gene and its promoter sequence
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
AU6724794A (en) GRB3-3 gene, its variants and their uses
DE60028217D1 (de) Zyklische depsipeptid-synthasen, deren gene und system zur massenproduktion von zyklischen depsipeptiden
DE60138621D1 (de) Neuartige glykosyltransferase-gene
DE69631899D1 (de) Xylanasen, für diese kodierende gene und anwendungen derselben
DE60331802D1 (de) Gen für Chlorohydrin und Hydroxycarbonsäureester asymmetrische Hydrolase
HUP0104598A1 (hu) Hepatocita-eredetű növekedési faktorból (HGF) és makrofágstimuláló proteinből (MSP) származó rekombináns proteinek
CA2419038A1 (en) Nucleic acid and protein increasing expression levels under salt stress
ATE354650T1 (de) Neuartige (r)-2-hydroxy-3-phenylpropionat (d- phenyllaktat) dehydrogenase und für diese kodierendes gen
ATE301199T1 (de) Beta-primeverosidase gen
CA2247087A1 (en) Flower organ-specific gene and its promoter sequence
ES2056410T3 (es) Procedimiento de produccion a partir de cepas de bacillus subtilis y procedimiento de preparacion de dichas cepas.
ATE286535T1 (de) Regulatorisches protein pke 83 aus humanen keratinozyten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee